Medicare Enrolled
Dr. Venkatachalam Mulukutla, M.D.
Interventional Cardiology · El Paso, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mulukutla from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mulukutla?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mulukutla
Dr. Venkatachalam Mulukutla is an interventional cardiology specialist in El Paso, TX, with 17 years of NPI registration. Based on federal Medicare data, Dr. Mulukutla performed 3,051 Medicare services across 1,581 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mulukutla received a total of $144,841 from 41 pharmaceutical and/or device companies across 714 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mulukutla is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 36% volume in TX
$144,841 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,051
Medicare services
Top 36% in TX for interventional cardiology
1,581
Unique beneficiaries
$106
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~179 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
922 | $0 | $0 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
612 | $88 | $309 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
276 | $40 | $231 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
196 | $134 | $642 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
161 | $10 | $48 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
94 | $117 | $415 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
70 | $51 | $216 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 63 | $946 | $3,900 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
60 | $19 | $345 |
| Midazolam injection, per 1 mg Administration of midazolam hydrochloride, a sedative medication, measured in 1 mg increments. |
54 | $0 | $0 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle while at rest and during stress. |
52 | $979 | $3,942 |
| New patient office visit, complex (60-74 min) | 42 | $151 | $595 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
40 | $110 | $477 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
36 | $19 | $79 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
36 | $623 | $2,031 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
35 | $67 | $209 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
33 | $14 | $154 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
32 | $81 | $936 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
32 | $2 | $73 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
29 | $38 | $147 |
| Injection, fentanyl citrate, 0.1 mg | 28 | $1 | $2 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
24 | $182 | $688 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
23 | $126 | $533 |
| Repair of left upper heart chamber with implant A surgical procedure to repair the left upper chamber of the heart using an implanted device, with review by a radiologist. |
19 | $582 | $2,385 |
| Transcatheter aortic valve replacement via femoral artery A minimally invasive procedure to replace a diseased aortic heart valve using a catheter inserted through the skin and femoral artery. |
17 | $559 | $4,027 |
| Cardiac catheterization | 15 | $788 | $3,018 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
14 | $51 | $239 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
14 | $143 | $525 |
| Nuclear stress test with CT scan A nuclear medicine imaging test that evaluates blood flow in the heart muscle at rest and during stress, performed alongside a concurrent CT scan. |
11 | $1,799 | $9,180 |
| PET scan of heart muscle blood flow A nuclear medicine imaging test that uses positron emission tomography (PET) to evaluate blood flow within the heart muscle. |
11 | $135 | $691 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.6% high complexity
52.4% medium
39.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$144,841
Total received (2018-2024)
Avg $20,692/year across 7 years
Top 4% in TX for interventional cardiology
41
Companies
714
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$81,076 (56.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$32,951 (22.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$30,813 (21.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$29,621
2023
$17,442
2022
$25,054
2021
$44,503
2020
$10,175
2019
$12,450
2018
$5,595
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Edwards Lifesciences Corporation
$85,219
W. L. Gore & Associates, Inc.
$19,447
ABIOMED
$15,866
Abbott Laboratories
$6,649
Boston Scientific Corporation
$5,941
BOSTON SCIENTIFIC CORPORATION
$2,329
Medtronic, Inc.
$2,135
Medtronic Vascular, Inc.
$1,041
Novartis Pharmaceuticals Corporation
$906
Bard Peripheral Vascular, Inc.
$819
Amgen Inc.
$615
Janssen Pharmaceuticals, Inc
$487
AstraZeneca Pharmaceuticals LP
$367
Inari Medical, Inc.
$361
Boehringer Ingelheim Pharmaceuticals, Inc.
$338
PFIZER INC.
$304
E.R. Squibb & Sons, L.L.C.
$267
Venclose Inc.
$264
Terumo Medical Corporation
$251
Penumbra, Inc.
$194
Philips Electronics North America Corporation
$191
Cardiovascular Systems Inc.
$125
Astellas Pharma US Inc
$125
Inspire Medical Systems, Inc.
$101
Philips North America LLC
$96
Ra Medical Systems, Inc.
$69
Teleflex LLC
$35
ARBOR PHARMACEUTICALS, INC.
$33
Chiesi USA, Inc.
$31
Merck Sharp & Dohme LLC
$30
Lexicon Pharmaceuticals, Inc.
$30
Amarin Pharma Inc.
$29
HeartFlow, Inc.
$20
Regeneron Healthcare Solutions, Inc.
$19
CORDIS US CORP.
$19
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$18
Kiniksa Pharmaceuticals, Ltd.
$17
Tactile Systems Technology Inc
$15
MEDICOMP INC
$14
Gilead Sciences, Inc.
$12
CVRx, Inc.
$11
Top 3 companies account for 83.2% of total payments
Associated products mentioned in payments ›
(6342) Intrasight Integrated · (9266) ELCA · (9520) IGT Devices Und · (BR5) Peripheral IVUS · AMPLATZER · AMPLATZER Occluders · AVVIGO Guidance System · Advisa · Allure Quadra RF CRT Pacemaker · Arcalyst · Assurity Pacemaker · BRILINTA · Barostim Neo System · CARDIOFORM Septal Occluder · CARDIOMEMS · CHANTIX · CROSSBOSS · Cardiac Monitor · Confirm Rx · CoreValve Evolut · Corlanor · Coronary Orbital Atherectomy System · CrossBoss · DABRA · Durata Defibrillation ICD Lead · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · ENTRESTO · EVRSF · Edarbi · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Edwards SAPIEN XT Transcatheter Heart Valve · Ellipse ICD · FARXIGA · FFRct · FLOWTRIEVER CATHETER · Flexitouch Plus · Fortify Assura · GENERAL STRUCTURAL HEART · GENERAL VASCULAR ACCESS · GENERAL VASCULAR ACCESS · GENERAL - STRUCTURAL HEART · GORE CARDIOFORM Septal Occluder · HARMONY · HAWKONE · HawkOne · Hornet 10 · IGT D Coronary · IGT D Peripheral · IGT_D Peripheral · IN.PACT Admiral · INSPIRE · Impella · Indigo · Inpefa · JARDIANCE · KENGREAL · LEQVIO · LEXISCAN · LINQ II · LifeVest · MAMBA · MANTA · MITRACLIP · Melody · Micra · Mitra Clip system · MitraClip System · Navicross · Optis Coronary Imaging System · Optisure Defibrillation ICD Lead · PRALUENT ALIROCUMAB INJECTION · Penumbra System · RAIN SHEATH · RESOLUTE ONYX · ROTABLATOR · ROTAPRO · Repatha · Resolute · Reveal LINQ · RotaWire and wireClip Torquer · Rotaglide · S · SAPIEN 3 Ultra RESILIA · SYMPLICITY G3 · SYNERGY · Stingray · Supera peripheral stent system · TR Band · Tendril Pacing Lead · VENASEAL · VERQUVO · VYNDAQEL · Vascepa · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO · Xience Sierra Coronary Stent · Xience Sierra Coronary Stent System · Zephyr Pacemaker
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (56%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 4% for interventional cardiology in TX.
Equivalent to $4,747 per 100 Medicare services performed
Geographic Context
Interventional cardiologists within 10 mi
12
Per 100K population
1.4
County median income
$58,859
Nearest hospital
THE HOSPITALS OF PROVIDENCE - MEMORIAL CAMPUS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Mulukutla is a clinical cardiology specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 4% of TX peers, with 17 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Mulukutla experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Mulukutla performed 922 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mulukutla receive payments from pharmaceutical companies?
Yes. Dr. Mulukutla received a total of $144,841 from 41 companies across 714 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mulukutla's costs compare to other interventional cardiologists in El Paso?
Dr. Mulukutla's average Medicare payment per service is $106. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mulukutla) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologists in El Paso
Browse interventional cardiologists in El Paso ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologists in TX
Interventional cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologists in TX
Which TX interventional cardiologists receive the most from drug and device companies.
By company
Edwards Lifesciences Corporation Payments to Doctors
See all physicians who received payments from Edwards Lifesciences Corporation.
By company
W. L. Gore & Associates, Inc. Payments to Doctors
See all physicians who received payments from W. L. Gore & Associates, Inc.
By company
ABIOMED Payments to Doctors
See all physicians who received payments from ABIOMED.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology